stars 1 stars 2 stars 3

iOMEDICO specializes in oncology clinical research We are experts and specialists in oncology and hematology, translating clinical questions into practical trial concepts to improve patient care. Together with our oncology network, we collect detailed clinical data from over 6000 new oncology patients each year. We are a full-service clinical research organization covering clinical phase I to IV studies, non-interventional studies and tumor registries. Our multidisciplinary team consists of highly qualified professionals, such as clinical oncologists, research scientists, biostatisticians and medical writers. together, we IMPROVE ONCOLOGY iOMEDICO started in 1993 by programming one of the first electronic data capture (EDC) systems with the aim of collecting clinical data in a timely, quality-managed and paperless manner. Today, we research new substances and treatment options in cooperation with over 1,400 experienced specialists from oncological practices, municipal clinics and university clinics as well as our partners from the pharmaceutical industry.

iOMEDICO Questions

The iOMEDICO annual revenue was $19.3 million in 2026.

Michael Pröschel is the CEO of iOMEDICO.

58 people are employed at iOMEDICO.

iOMEDICO is based in Freiburg, Baden-Württemberg.

Top iOMEDICO Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users